870853 | ST1326
(R)-3-(3-tetradecylureido)-4-(trimethylammonio)butanoate
ST1326
(R)-3-(3-tetradecylureido)-4-(trimethylammonio)butanoate
Hygroscopic
No
Light Sensitive
No
Molecular Formula
C22H45 N3O3
Percent Composition
C 66.12%, H 11.35%, N 10.52%, O 12.01%
Purity
>99%
Stability
1 year
Storage Temperature
-20°C
CAS Number
250694-07-6
CAS Registry Number is a Registered Trademark of the American Chemical Society
CAS Registry Number is a Registered Trademark of the American Chemical Society
Formula Weight
399.611
Exact Mass
399.346
Synonyms
Teglicar
- ChemDraw File
- 3D Structure
- Structure
- Safety Data Sheet
- Certificate of Analysis (Lot No. 870853P-1MG-A-010 and 6262PGA010)
- Certificate of Analysis (Lot No. 870853P-1MG-B-010 and 6262PGB010)
- Certificate of Analysis (Lot No. 870853P-1MG-C-010 and 6262PGC010)
- Certificate of Analysis (Lot No. 870853P-1MG-D-010 and 6262PGD010)
- Certificate of Analysis (Lot No. 870853P-1MG-E-010 and 6262PGE010)
- Certificate of Analysis (Lot No. 870853P-CONF-A-010 and 6262PWA010)
Grønningsæter IS, Reikvam H, Aasebø E, Bartaula-Brevik S, Tvedt TH, Bruserud Ø, Hatfield KJ. Targeting Cellular Metabolism in Acute Myeloid Leukemia and The Role of Patient Heterogeneity. Cells. 2020 May 7;9(5):1155. doi: 10.3390/cells9051155. PMID: 32392896; PMCID: PMC7290417.
PubMed ID: 32392896Cheng S, Wang G, Wang Y, Cai L, Qian K, Ju L, Liu X, Xiao Y, Wang X. Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARγ-mediated pathway in bladder cancer. Clin Sci (Lond). 2019 Aug 7;133(15):1745-1758. doi: 10.1042/CS20190587. PMID: 31358595.
PubMed ID: 31358595